Currently there is no FDA regulation for CBD products, which raises questions about CBD product safety and efficacy. Marcel Bonn-Miller has conducted seminal work on the interrelations between cannabis and a range of health conditions. He spoke during a session at Aspen Ideas: Health.
Watch the full discussion, “CBD: Hype or Hope?” here: https://youtu.be/1D2WG9YyZaU
This conversation was recorded during Aspen Ideas: Health in Aspen, Colorado. Presented by the Aspen Institute, the three-day event opens the Aspen Ideas Festival and features more than 200 speakers engaging with urgent health care challenges and exploring cutting-edge innovations in medicine and science.
Learn more at https://www.aspenideas.org